Extracellular vesicle proteome unveils cathepsin B connection to Alzheimer’s disease pathogenesis
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Extracellular vesicles (EVs) are membrane vesicles that are released extracellularly and considered to be implicated in the pathogenesis of neurodegenerative diseases including Alzheimer’s disease. Here, CSF EVs of 16 ATN-classified cases were subjected to quantitative proteome analysis. In these CSF EVs, levels of 11 proteins were significantly altered during the ATN stage transitions (P < 0.05 and fold-change > 2.0). These proteins were thought to be associated with Alzheimer’s disease pathogenesis and represent candidate biomarkers for pathogenic stage classification. Enzyme-linked immunosorbent assay analysis of CSF and plasma EVs revealed altered levels of cathepsin B (CatB) during the ATN transition (seven ATN groups in validation set, n = 136). The CSF and plasma EV CatB levels showed a negative correlation with CSF amyloid-β42 concentrations. This proteomic landscape of CSF EVs in ATN classifications can depict the molecular framework of Alzheimer’s disease progression, and CatB may be considered a promising candidate biomarker and therapeutic target in Alzheimer’s disease amyloid pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These factors are potentially involved in early AD pathology through synaptic aberrant pruning and rapid abnormal metabolism of APP, respectively.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [383]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Proteomic studies found elevated C1q levels in MCI and AD groups, and increased CatB concentration in CSF Aβ42-positive cases.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [383]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Proteomic studies found elevated C1q levels in MCI and AD groups, and increased CatB concentration in CSF Aβ42-positive cases.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [383]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · cited 1×
“41 However, several reports have shown that CatB is involved in A β processing; in an in vitro study, CatB cleaved APP much faster than BACE1.”
BackgroundBiological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926 · cited 1×
“7,8 EVs are released from a variety of cells, including those in the CNS, 9 and it has been reported that those derived from the CNS contain molecules such as A β , its catabolic enzymes, and tau, which all play important roles in the pathogenesis of AD.”
BackgroundIsolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766 · cited 1×
“EVs were collected from CSF and plasma by differential ultracentri-fugation, 21 as different isolation methods were tested to determine if they produced equivalent results.”
Method
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Advances in Integrated Multi-omics Analysis for Drug-Target Identification
Du, P., Fan, R., Zhang, N., Wu, C., & Zhang, Y. (2024) · Biomolecules · doi:10.3390/biom14060692 · Cited by 119
Li, B., Wu, W., Xu, W., Qian, H., & Ji, C. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03768-2 · Cited by 102
Extracellular vesicles: translational research and applications in neurology
Manolopoulos, A., Yao, P. J., & Kapogiannis, D. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01080-z · Cited by 63
Alzheimer’s disease pathogenesis: standing at the crossroad of lipid metabolism and immune response
Wang, Z., Zhang, L., & Qin, C. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00857-6 · Cited by 65
Zanirati, G., dos Santos, P. G., Alcará, A. M., Bruzzo, F. T. K., Ghilardi, I. M., Wietholter, V., Xavier, F. A. C., Gonçalves, J. I. B., Marinowic, D. R., Shetty, A. K., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137371 · Cited by 52
Pei, J., Palanisamy, C. P., Jayaraman, S., Natarajan, P. M., Umapathy, V. R., Roy, J. R., Thalamati, D., Ahalliya, R. M., Gopalakrishnan, V. K., & Mironescu, M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102359 · Cited by 56
Zheng, J., Jiang, X., Bai, S., Lai, M., Yu, J., Chen, M., Zhou, R., Jia, Y., Yan, H., Liang, Z., et al. (2025) · Advanced Materials · doi:10.1002/adma.202505262 · Cited by 34
Taha, H. B. (2025) · npj Dementia · doi:10.1038/s44400-024-00002-y · Cited by 34
Zhang, X., Fu, M., Wang, Y., & Wu, T. S. (2025) · Frontiers in Drug Delivery · doi:10.3389/fddev.2025.1644633 · Cited by 45
Neuron-derived extracellular vesicle-based diagnostics for Tau and Alzheimer’s disease
Chinnathambi, S., Kumarappan, M., Malik, S., Velmurugan, G., & Chandrashekar, M. (2025) · Brain Network Disorders · doi:10.1016/j.bnd.2024.12.006 · Cited by 21
Recent advances of fluorescent probe for the conjugated enzymes closely related to clinical diseases
Zhang, R.-W.-Y., Zhang, H., Li, Q., Li, F.-P., Zhang, R., Zhao, W., Liu, H., Hu, Z., & Wang, K. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216471 · Cited by 17
Targeted delivery of BACE1 siRNA for synergistic treatment of Alzheimer's disease
Li, Z., Yang, J., Li, J., Zhao, S., Jiang, S., Liu, W., Li, X., Zhang, S.-M., Du, H., Ni, J., et al. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00503-7 · Cited by 23
Dematteis, G., Gong, C., Malecka, J., Tonelli, E., Genazzani, A. A., Tapella, L., Eleuteri, A. M., Lim, D., & Bonfili, L. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01793-9 · Cited by 16
Jiang, M., Ge, Z., Yin, S., Liu, Y., Gao, H., Lu, L., Wang, H., Chen, L., Ni, J., Pan, Y., et al. (2024) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.14109 · Cited by 15
Yu, Y., Xiao, W., Ma, Z., Yi, X., Zhong, T., & Li, Z. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03528-x · Cited by 9
Kamra, K., Lalam, S. K., Srivastava, S., Arumugam, M. K., Boopathy, L. K., Takkar, S., Xia, Z., & Subramanian, S. P. (2026) · Health Science Reports · doi:10.1002/hsr2.72638 · Cited by 10
Khushboo, Manisha, M., Aggarwal, S., Subhash, S., Raghav, N., Dahiya, H., & Mor, N. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108488 · Cited by 5
Zheng, K., Huang, H., Liu, D., Brazhe, N. A., Chen, J., & Zhu, L. (2025) · MedComm · doi:10.1002/mco2.70368 · Cited by 5
Alam, P., Sharma, P. K., Kirtipal, N., & Akhtar, A. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11388-z · Cited by 3
Drug discovery research with iPSC models of neurodegenerative diseases
Adachi, M., Banno, H., & Inoue, H. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.104985 · Cited by 3
Bernal‐Vicente, B. N., Ponce, I., Ríos‐Castro, E., Moreno‐Castilla, P., & Tovar‐y‐Romo, L. B. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70350 · Cited by 3
AI-driven biomarker learning for the early diagnosis of neurodegenerative diseases: ABLEDx
Zhu, Q., Wu, S., Huang, P., Sun, Q., Liu, Z., Zhu, X., Lee, L. P., & Liu, F. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04072-3 · Cited by 4
Extracellular vesicle therapeutics in Alzheimer’s disease: mechanisms, progress, and prospects
Fang, Y., Hao, X., & Fang, B. (2026) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2025.158 · Cited by 3
Shao, W., Wang, K., Liu, Y., Zhang, H., Sun, Z., & Zhou, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125580 · Cited by 6
Aldaghi, F. S., Siahpoosh, Z., Salehi, Z., Mashayekhi, F., & Sohrabnezhad, S. (2026) · Brain and Behavior · doi:10.1002/brb3.71615 · Cited by 3
Computer-aided Drug Design for Alzheimer's Disease: Recent Advancements and Future Perspectives
Rohilla, S., & Goyal, G. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266343814250713100224 · Cited by 2
Penna, E., Su, W., Reece, T., Braga, M., Shigemitsu, H., Ta, K., Baudry, M., & Bi, X. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102870 · Cited by 3
Wu, Y., Cleverley, K., & Wiseman, F. K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316822 · Cited by 1
Extracellular vesicle omics assisted disease management
Liu, P., Zhuang, W., Sun, J., & Xie, H.-Y. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118621 · Cited by 1
The Need for Standardization of Extracellular Vesicle Characterization Methods
Nelson, B. C., Wintenberg, M., Schaffter, S. W., & Vreeland, W. N. (2025) · Springer eBooks · doi:10.1007/978-3-031-89270-7_2 · Cited by 2
Wu, C., Yu, H., Zhao, N., Wang, Q., Zhang, Z., & Yang, M. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.108203 · Cited by 3
Xin, J., Liu, J., Dong, H.-M., Yu, H., Xiao, Z., Hu, J.-N., Jiang, Q., Zhu, Y.-P., Feng, L., Feng, Y., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3243-2 · Cited by 2
Puthiyattil, N., Varughese, D., Mani, B. M., Babu, R. S., Nair, K. S., George, R. L., Ramitha, P. A., Dogra, N., Mathew, M., Varghese, M. T., et al. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103178 · Cited by 3
Zhang, X., Ding, N., Chen, B. B., Li, D.-W., Liu, H., & Ruo-Can, Q. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c05551 · Cited by 1
Song, W., Zhang, J., Ruan, G., Wang, X., Li, B., Wu, D., Zhu, A., Zhao, L., & Ling, H. (2026) · BMC Neurology · doi:10.21203/rs.3.rs-3977553/v1
Preclinical: Drug Target Identification and Validation in Humans
Singh, H., & Kaur, R. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95502-7.00145-7
Wu, Y., Gan, Q., Su, X., Ding, Y., Liu, Q., Wang, J., Zhang, Y., Zhang, N., & Wu, K. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111263
Targeted delivery of BACE1 siRNA for synergistic treatment of Alzheimer's diseasePreprint
Li, Z., Yang, J., Li, J., Zhao, S., Jiang, S., Liu, W., Li, X., Zhang, S.-M., Du, H., Ni, J., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-5825677/v1
Extracellular Vesicles as Biomarkers of Alzheimer Disease and Related Dementias
Mianoor, Z., Phelps, J., & Badhwar, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_18
Aβ Modulates Extracellular Vesicles Proteomic Profile Impacting Phosphorylation Mediators
Vaz, M., Martins, T. S., Trigo, D., Silva, O. A. B. D. C. E., Amado, F. M. L., Vitorino, R. M. P., & Henriques, A. G. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05343-0 · Cited by 1
Extracellular Vesicles in Tauopathies: Mechanisms and Applications
Nannuri, V., Ababneh, E., Rayes, S. E., Smith, J., Sugaya, K., & Zhao, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041998 · Cited by 1
Li, Y., Sun, C., & Liu, Q. (2026) · Neuropharmacology and Therapy · doi:10.15212/npt-2025-0007 · Cited by 1
Hunter, T., Silva, N. M. L. E., de Freitas, G. B., Rody, T., Santos, L. E., Zhang, J., Bullock, A., Tartaglia, M. C., Abraham, S. A., Nicolini, C., et al. (2026) · Brain Communications · doi:10.1093/braincomms/fcag085
Extracellular vesicles in autoimmune diseases and immunotherapy
Pareek, A., Yadav, S. K., Kumar, J., Sarkar, B., & Goyal, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36641-3.00006-1
Vermeulen, I., Parmentier, Y., Barber, J., François, A., Chadli, L., Provost, N., Isin, E. M., Ogungbenro, K., Galetin, A., Rostami‐Hodjegan, A., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06074-6
Zhang, S., Zhang, C., Mao, J., & Ni, J. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108478
Metadata
- Authors
- Yuyama, K., Sun, H., Fujii, R., Hemmi, I., Ueda, K., & Igeta, Y.
- Affiliations
- Hokkaido University (JP)
- Japanese Foundation For Cancer Research (JP)
- Japanese Red Cross College of Nursing (JP)
- Toranomon Hospital (JP)
- Corresponding author
- Igeta, Yukifusa
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-12-10
- Volume
- 147
- Issue
- 2
- Pages
- 627-636
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC10834236
- OpenAlex
- W4389522425
- Cited by
- 47
- References
- 54
- Citations by year
- 2026: 15 · 2025: 25 · 2024: 7
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- KAKENHI (22K07341)
- Japan Society for the Promotion of Science
- Okinaka Memorial Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- extracellular vesicles, cathepsin B, Alzheimer's disease, amyloid-beta 42, cerebrospinal fluid, plasma extracellular vesicles, biomarkers, proteome, amyloid pathology, therapeutic target
- MeSH terms
- Extracellular Vesicles, Alzheimer Disease, Cathepsin B, Humans, Biomarkers, Amyloid beta-Peptides, tau Proteins, Proteome, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.